Atea Pharmaceuticals, Inc.
AVIR
Revenue
192.18M
▲159.37M▲485.72%
3 Months ChangeAssets
510.38M
▼-42.65M▼-7.71%
3 Months ChangeLiabilities
33.91M
▼-14.74M▼-30.30%
3 Months ChangeFree Cash Flow
-59.05M
▼-59.05M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092914
2024-08-07
Form 8-K
ID: 0001193125-24-195895
2024-06-21
Form 8-K
ID: 0001193125-24-165886
2024-05-14
Form 10-Q
ID: 0000950170-24-059699
2024-05-14
Form 8-K
ID: 0001193125-24-138249
2024-02-28
Form 8-K
ID: 0001193125-24-050724
2023-11-08
Form 10-Q
ID: 0000950170-23-061213
2023-11-08
Form 8-K
ID: 0001193125-23-273532
2023-08-08
Form 10-Q
ID: 0000950170-23-039920
2023-08-08
Form 8-K
ID: 0001193125-23-206247